Top compounds associated with response to CDC16


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.064 0.08
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.065 0.08
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.073 0.08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.08
mRNA PD318088 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA alvocidib CTRPv2 pan-cancer AAC 0.088 0.08
mRNA AZD6244 CCLE pan-cancer AAC 0.077 0.08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.08
mRNA alisertib CTRPv2 pan-cancer AAC -0.058 0.08
Download CSV